[Selective intraarterial axillar artery thrombolysis in a neonate: angiographic and thermographic serial time course].
Arterial thrombotic vascular occlusions in the neonatal period are rare. Intraarterial thrombolytic therapy in infants and children is unchanged rarely used but can be very effective. Thrombolytic therapy in adults is well established and a summary of clinical and pharmacologic aspects exists of different thrombolytic agents. Recombinant-Tissue-Plasminogen-Activator (rTPA) is increasingly used in thrombolytic therapy in infants and children in the last years. We report thrombolysis of axillar arterial thrombosis with rTPA in a premature infant. Additional thermographic images were performed, which were very helpful in the clinical monitoring of the newborn.
Lachmann
R
R
Institut für Klinische Radiologie, Universität Heidelberg, Universitätsklinikum Mannheim. ricarda.lachmann@rad.ma.uni-heidelberg.de
Dinter
D
D
Schaible
T
T
Düber
C
C
Neff
K W
KW
D015901:Angiography, Digital Subtraction; D001132:Arm / Q000098:blood supply*; D001366:Axillary Artery; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000175:diagnosis / Q000188:drug therapy*; D007511:Ischemia / Q000151:congenital* / Q000175:diagnosis / Q000188:drug therapy; D008991:Monitoring, Physiologic; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use; D012867:Skin / Q000098:blood supply*; D012881:Skin Temperature / Q000187:drug effects; D013817:Thermography; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000151:congenital* / Q000188:drug therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator